Sasaki et al.: "Newly developed type 1 diabetes after coronavirus disease 2019 vaccination: A case report"
by Paul Alexander
In recipients with the disease-susceptible haplotypes, one should be cautious about autoimmune responses for several months after the vaccination.
‘A 73-year-old Japanese woman received two doses of Moderna COVID-19 vaccine. Four weeks after the second vaccination, her glycemic control began to deteriorate, and 8 weeks after the second vaccination, the patient was diagnosed with new-onset type 1 diabetes that was strongly positive for autoantibodies and showed a disease-susceptible human leukocyte antigen haplotype, DRB1*04:05:01-DQB1*04:01:01.’